CAR T CELL THERAPY MARKET Global Market Analysis, Insights, Trends, and Opportunity Inference, 2028 REPORT DESCRIPTION CAR T Cell Therapy Market – A Revolution in Cancer Treatment Over the last few years, CAR T Cell therapy has gained wide recognition in the healthcare industry. CAR T cell is an innovative technique that involves removal of T Cells from patient’s blood before reinsertion using a genetically altered mechanism. The technology is still in the nascent stage; however, is expected to grow at double digit growth rate creating multi-billion absolute dollar opportunity for industry players in the near future. As of 2016, just over 40 companies are engaged in CAR T cell therapy market. Novartis International AG, Juno Therapeutics, and Kite Pharma Inc. are the only players that are expected to launch products by 2018. With long impending clinical trials and research activities carried out using chimeric antigen receptor cells (CAR-T) cells, these players in the pharmaceuticals industry are expected to launch various products in 2017 and commercialize them in the following two to three years. Get Free PDF Research Brochure for more Professional and Technical Insights : https://www.coherentmarketinsights.com/insight/request-sample/102 Market Taxonomy This report segments the CAR T cell therapy market on the basis of antigen type, and therapeutic applications. On the basis of antigen, CAR T cell therapy market is segmented as CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, EGFRvlll, and others. On the basis of therapeutic applications, CAR T cell therapy market is segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, non-hodgkin leukemia, multiple myeloma, pancreatic cancer, neuroblasta, breast cancer, acute myeloid leukemia, hepatocellular carcinoma, colorectal cancer, and other therapeutic applications. REPORT DESCRIPTION Market Dynamics CAR T cell therapy is expected to be a game changer post its commercialization creating revenue opportunities for players in the CAR T cell therapy market. Moreover, it is expected to help with effective diagnosis of acute lymphoblastic leukemia (ALL) in B cells of children. Introduction of the drug is expected to be especially beneficial for leukemia patients. According to the U.S. National Cancer Institute, over 340,000 people in the U.S., suffered from leukemia in 2015, with an estimated 1.5% of the population in the country expected to be detect with leukemia once in their lifetime. Growing prevalence rate and increasing demand for effective treatment modalities is expected to pave way for market growth over the forecast period. Browse Global Strategic Business Report @ https://www.coherentmarketinsights.com/market-insight/car-t-celltherapy-market-102 Diversification of CAR T Cell in other therapeutics application is expected to create lucrative market opportunities for market players Currently, Juno Therapeutics along with Kite Pharma and Novartis are working on CD 19 antigen—responsible for blood cancers. These companies also have a product roadmap to commercialize products based on CD 30 and 22 responsible for solid cancers. FDA approval of these products by 2025 is projected to drive the market growth over the latter half of the forecast period. REPORT DESCRIPTION CD 19 to dominate the market throughout the forecast period Acute lymphoblastic leukemia (ALL) is highly prevalent among children. Adults account for over 40% cases of ALL. Changing lifestyle along with increasing incidence of cancer among children necessitates an effective treatment approach in the healthcare industry for effective treatment of the same. As a result, CAR- T cell therapy has emerged as one of the potential therapies to address this issue. CD-19 marker is highly effective in tackling the growing incidence problem of ALL. The CD-19 antigen CAR T Cell segment is expected to be valued at US$ 1.2 billion by 2023 and is expected to continue dominate the market (in terms of revenue) through the remainder of the forecast period. Request For Customization@ https://www.coherentmarketinsights.com/insight/request-customization/102 Global Car T Cell Therapy Market : Competitive Landscape It profiles leading players in the global CAR T Cell Therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans Global Car T Cell Therapy Market : Key Players Key companies covered as a part of this study include Juno Therapeutics, Kite Pharma Inc., Novartis International AG, Bellicum Pharmaceuticals Inc., Celgene Corporation, and Cellectis ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators Private and Government organization Distributors, Retailors and Value Added Resellers Outsourcing Companies Healthcare IT Solutions Developers Universities and Business Schools. ABOUT US KEY STATS RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS 100+ Insights Published Per Year 150+ Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS CUSTOMIZED SOLUTIONS SURVEY RESEARCH EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702
The Global Car T Cell Therapy Market is expected to be valued at US$ 8.5 Billion by 2028, as analyzed by Coherent Market Insights. Increasing demand for genetically engineered treatment approach for high success rate in cancer treatment along with growing cancer incidence rate are key factors driving demand for CAR T cell therapy products worldwide.
© Copyright 2024 Paperzz
